Public Policy Evaluation: the Case of the Green Prescription (NCT07234617) | Clinical Trial Compass
RecruitingNot Applicable
Public Policy Evaluation: the Case of the Green Prescription
France210 participantsStarted 2025-11-10
Plain-language summary
Numerous studies have highlighted the harmful effects of pesticide exposure during the prenatal period. Food is one of the main vectors of exposure to pesticides, particularly glyphosate, which is the most widely used herbicide. Observational studies have highlighted their effects on health, but few interventional studies have been conducted to identify effective interventions to reduce or eliminate environmental risks. In 2022, the City of Strasbourg implemented the "Ordonnance Verte" (Green Prescription) program, giving all pregnant women in the city access to a weekly basket of organic and local vegetables for several months, as well as awareness-raising workshops on endocrine disruptors and healthy eating. The objective of this study is to assess whether this type of program reduces pregnant women's exposure to pesticides compared to women who continue to eat according to their usual habits. If conclusive, this type of assessment would play a key role in facilitating the rollout of similar initiatives on a larger scale and protecting the health of pregnant women and future children.
Who can participate
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Be a woman
* Be less than 32 weeks pregnant
* Be registered with the "Ordonnance Verte" program
* Have agreed, when registering for the program, to be contacted by a research team
* Be affiliated with a social security system or be a beneficiary of such a system.
* Be fluent in French.
* Be over 18 years of age
* Be able to understand the objectives and risks associated with the research and give dated and signed informed consent
* Have a telephone and internet access
Exclusion Criteria:
* Participation in a study on nutrition or any other studies likely to affect exposure to the compounds under investigation
* Inability to provide informed consent (difficulties in understanding on the part of the pregnant woman, etc.)
* Being under judicial protection
* Being under guardianship or conservatorship
* Working in the agricultural sector (farmer, employee, apprentice)
* Living with someone who works in the agricultural sector (farmer, employee, apprentice)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in urinary pesticide concentrations over the two-week study period in the intervention group
Timeframe: Day 0 and at 2 weeks
2
Difference in urinary pesticide concentrations between the two groups